A CD44−/CD24+ phenotype is a poor prognostic marker in early invasive breast cancer

Author： Ahmed Mohamed   Aleskandarany Mohammed   Rakha Emad   Moustafa Radwa   Benhasouna Ahmed   Nolan Christopher   Green Andrew   Ilyas Mohammad   Ellis Ian  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.133, Iss.3, 2012-06, pp. : 979-995

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic significance of CD24 and claudin-7 immunoexpression in ductal invasive breast cancer

By              

Oncology Reports, Vol. 27, Iss. 1, 2012-01 ,pp. : 28-38

Spandidos Publications

Access to resources Recommend Favorite

Prognostic Value of Immunohistochemically Detected CD44 Isoforms CD44v5, CD44v7-8 in Human Breast Cancer

By Tempfer C.   Losch A.   Heinzl H.   Hausler G.   Hanzal E.   Kolbl H.   Breitenecker G.   Kainz C.  

European Journal of Cancer, Vol. 32, Iss. 11, 1996-10 ,pp. : 2023-2025

Elsevier

Access to resources Recommend Favorite

The role of CD44+/CD24-/low biomarker for screening, diagnosis and monitoring of breast cancer

By                  

Oncology Reports, Vol. 31, Iss. 3, 2014-01 ,pp. : 1127-1132

Spandidos Publications

Access to resources Recommend Favorite

CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer

By                    

Oncology Reports, Vol. 29, Iss. 4, 2013-01 ,pp. : 1570-1578

Spandidos Publications

Access to resources Recommend Favorite

CD24 expression as a marker for predicting clinical outcome and invasive activity in uterine cervical cancer

By                          

Oncology Reports, Vol. 34, Iss. 5, 2015-01 ,pp. : 2282-2288

Spandidos Publications

Access to resources Recommend Favorite